European Commission approves Roche’s Gavreto to treat adults with RET fusion-positive advanced non-small cell lung cancer Read more
Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022 Read more
New analyses of two AZD7442 COVID-19 phase-III trials in high-risk populations confirm robust efficacy and long-term prevention Read more
Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from US FDA Read more
Alembic Pharmaceuticals’s joint venture Aleor Dermaceuticals receives US FDA final approval for Mupirocin Cream USP, 2% Read more
Cipla launches Spirofy, strengthens its lung leadership position by facilitating early diagnosis for COPD1 Read more